I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.1 SEK 2.9% Market Closed
Market Cap: 375.7m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Initiator Pharma A/S
Operating Expenses Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Operating Expenses
-kr27m
CAGR 3-Years
-37%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Operating Expenses
-kr12.4B
CAGR 3-Years
-43%
CAGR 5-Years
-42%
CAGR 10-Years
-35%
Zealand Pharma A/S
CSE:ZEAL
Operating Expenses
-kr1.2B
CAGR 3-Years
0%
CAGR 5-Years
-15%
CAGR 10-Years
-19%
Ascendis Pharma A/S
NASDAQ:ASND
Operating Expenses
-€625.2m
CAGR 3-Years
-14%
CAGR 5-Years
-25%
CAGR 10-Years
-42%
B
Bavarian Nordic A/S
CSE:BAVA
Operating Expenses
-kr2.7B
CAGR 3-Years
-41%
CAGR 5-Years
-36%
CAGR 10-Years
-16%
Bioporto A/S
CSE:BIOPOR
Operating Expenses
-kr82m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-10%

See Also

What is Initiator Pharma A/S's Operating Expenses?
Operating Expenses
-27m DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Operating Expenses amounts to -27m DKK.

What is Initiator Pharma A/S's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-16%

Over the last year, the Operating Expenses growth was 35%. The average annual Operating Expenses growth rates for Initiator Pharma A/S have been -37% over the past three years , -16% over the past five years .

Back to Top